Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management

Published:2017-07 Issue: Volume:58 Page:70-76
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Sznol Mario,Postow Michael A.,Davies Marianne J.,Pavlick Anna C.,Plimack Elizabeth R.,Shaheen Montaser,Veloski Colleen,Robert Caroline

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference43 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010

2. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma;Robert;N Engl J Med,2011

3. Immune checkpoint blockade in cancer therapy;Postow;J Clin Oncol,2015

4. Managing immune checkpoint-blocking antibody side effects;Postow;Am Soc Clin Oncol Educ Book,2015

5. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination;Boutros;Nat Rev Clin Oncol,2016

Cited by 227 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of glucocorticoid replacement therapy in patients with pituitary disease: A new perspective for personalized replacement therapy;Reviews in Endocrine and Metabolic Disorders;2024-08-22

2. Immunotherapy for renal cell carcinoma: New therapeutic combinations and adverse event management strategies: A review;Medicine;2024-07-26

3. Immunotherapy induced adrenal insufficiency: an underdiagnosed cause of persistent hypotension in cancer;Journal of Community Hospital Internal Medicine Perspectives;2024-07-02

4. The role of cytokines in neuroimmunoendocrine mechanisms of thyroid pathology;Molekulyarnaya Meditsina (Molecular medicine);2024-06-18

5. A Curious Case of Diabetic Ketoacidosis Secondary to Avelumab;Cureus;2024-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3